Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26
India’s pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various ...
Latest Post
Agri outlook: ICRA pegs Q1 FY26 farm GVA growth at 4.5%, mixed sowing and rainfall dip weigh on momentum
ICRA forecasts a moderation in agricultural GVA growth to 4.5% in Q1 FY26, down from 5.4% in the previous quarter, due to mixed sowing patterns. ...
FPI flows reverse: Foreign investors pull Rs 17,741 crore from equities in July; US tariffs trigger sharp selloff in last week of month
Foreign portfolio investors became net sellers in July, withdrawing Rs 17,741 crore from Indian equities due to escalating global trade tensions and reciprocal tariffs imposed ...
ARCIL IPO: Avenue Capital-backed ARCIL files IPO draft papers with Sebi; GIC to exit, SBI to pare stake
Asset Reconstruction Company (India) Ltd (ARCIL), backed by Avenue Capital Group, has filed its DRHP with Sebi for an IPO consisting entirely of an offer ...
Volvo India’s gear shift: Changes EV-only plan; ICE models to stay amid slow uptake
Volvo’s Electric U-Turn: Why the Brand Isn’t Ditching Petrol Just Yet Remember when Volvo declared it was going all-electric by 2030? The automotive world took ...
Elon Musk-led Tesla to pay $243 mn in Florida crash case: Jury finds autopilot technology partly at fault; EV maker calls verdict ‘wrong’
When Autopilot Isn’t: Tesla Hit with $243M Verdict in Florida Crash The hum of electric engines and the promise of hands-free driving – that’s the ...